Extracorporeal photopheresis for the treatment of early‐stage mycosis fungoides |
| |
| Authors: | Daniel J. Lewis Madeleine Duvic |
| |
| Affiliation: | 1. School of Medicine, Baylor College of Medicine, Houston, Texas;2. Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| |
| Abstract: | Extracorporeal photopheresis (ECP) has been used for nearly 30 years in the treatment of cutaneous T‐cell lymphoma. However, current clinical practice largely reserves ECP for patients with late‐stage mycosis fungoides (MF) or Sézary syndrome or for those who are refractory to other therapies. We briefly describe a 48‐year‐old male who experienced long‐term complete remission of his patch MF disease with ECP, and we suggest a role for ECP in the treatment of early‐stage MF given evidence of its efficacy, safety, and tolerability. |
| |
| Keywords: | early stage extracorporeal photopheresis Mycosis fungoides Sé zary syndrome |
|
|
